HomeAI · summaries
Storia in 3 fonti
Emcure subsidiary Gennova to transfer mRNA business to Immunoscript Life Science for ₹139 crore
Emcure's Gennova transfers its mRNA business to Immunoscript Life Science for ₹139 crore, focusing on core biotech operations.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Emcure subsidiary Gennova to transfer mRNA business to Immunoscript Life Science for ₹139 crore
Emcure's Gennova transfers its mRNA business to Immunoscript Life Science for ₹139 crore, focusing on core biotech operations.
- ·
Emcure consolidates stake in Gennova, under stewardship of promoter family scion
Gennova is a ₹49-crore company and it mRNA business, at ₹6.47 crore, represented 0.71% of consolidated revenue of the company of ₹911.58 crore, Emcure said
